TCM
Tekla Capital Management Portfolio holdings
AUM
$2.56B
1-Year Return
18.15%
This Quarter Return
+13.64%
1 Year Return
+18.15%
3 Year Return
+62.34%
5 Year Return
+140.22%
10 Year Return
+499.57%
AUM
$2.46B
AUM Growth
+$126M
(+5.4%)
Cap. Flow
-$109M
Cap. Flow
% of AUM
-4.43%
Top 10 Holdings %
Top 10 Hldgs %
40.31%
Holding
213
New
10
Increased
47
Reduced
69
Closed
17
Top Buys
| 1 |
Pfizer
PFE
|
$23.5M |
| 2 |
Merck
MRK
|
$21.2M |
| 3 |
Welltower
WELL
|
$14.9M |
| 4 |
Eli Lilly
LLY
|
$10.2M |
| 5 |
CELG
Celgene Corp
CELG
|
$8.65M |
Top Sells
| 1 |
Biogen
BIIB
|
$19.1M |
| 2 |
Johnson & Johnson
JNJ
|
$18.8M |
| 3 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$16.3M |
| 4 |
AbbVie
ABBV
|
$13.9M |
| 5 |
Thermo Fisher Scientific
TMO
|
$13.5M |
Sector Composition
| 1 | Healthcare | 94.43% |
| 2 | Real Estate | 2.93% |
